Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Biophotonics Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Technology (In-vivo, and In-vitro), End User (Tests and Components, Medical Therapeutics, Medical Diagnostics, Non-Medical Application), Application (Surface Imaging, Inside Imaging, See-through Imaging, Microscopy, Biosensors, Analytical Sensing, Spectromolecular), and Regions (North America, Asia Pacific, Europe, and Latin America Middle East and Africa)
... Analytical Sensing, Spectromolecular), and Regions (North America, Asia Pacific, Europe, and Latin America Middle East and Africa) Market Overview: Biophotonics is the study of optical processes in biological systems, both those that occur naturally and ... Read More
-
Glioblastoma Multiforme (GBM) - Epidemiology Forecast - 2032
... (Germany, Spain, Italy, France), the United Kingdom, and Japan. Geography Covered The United States The EU-4 (Germany, France, Italy, and Spain), and the United Kingdom Japan Study Period: 2019-2032 Glioblastoma Multiforme Disease Understanding and Treatment ... Read More
-
Typhoid Fever - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Recurrent Clostridioides difficile Infection (rCDI) - Pipeline Insight, 2022
... (rCDI) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Short Bowel Syndrome - Pipeline Insight, 2022
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Cluster Headache Syndrome- Pipeline Insight, 2022
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Germany Post-Traumatic Stress Disorder (PTSD) Market - Industry Trends and Forecast to 2030
... to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market Segmentation Germany Post-Traumatic Stress Disorder (PTSD) ... Read More
-
Myotonic Dystrophy - Market Insight, Epidemiology And Market Forecast - 2032
... as well as the market trends of DM in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The myotonic dystrophy (DM) market report provides current treatment practices, emerging drugs, market ... Read More
-
Amyotrophic Lateral Sclerosis - Market Insight, Epidemiology And Market Forecast - 2032
... well as the ALS market trends in the United States, EU-4 (Germany, France, Italy, and Spain), the United Kingdom, Japan and China The ALS market report provides current treatment practices, emerging drugs, ALS market share ... Read More
-
Messenger RNA (mRNA) Vaccines & Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... Messenger Ribonucleic Acid (mRNA) is a term that refers to a single protein-coding gene in the genome that conforms as the basis for protein synthesis in cells. mRNA vaccines and treatments are made in laboratories ... Read More
-
Epilepsy Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... a significant impact on the market's growth as several neurology activities, such as medical training and research, were disrupted due to the pandemic. The outbreak not only impacted the epilepsy patients but also had an ... Read More
-
Precision Cancer Therapeutics, 2022
... 35 and 40 million people are living with cancer and nearly 10 million people lose the battle annually. The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, ... Read More
-
Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Pontine Glioma (Oncology) pipeline landscape. Pontine gliomas are highly aggressive and difficult to treat brain tumors found at the base of the brain. One of the most common types is ... Read More
-
Hepatitis C Virus Envelope Protein E2 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes. The latest report Hepatitis C Virus Envelope Protein E2 - Drugs In Development, 2022, outlays comprehensive information on the Hepatitis ... Read More
-
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Kaposi Sarcoma (Infectious Disease) pipeline landscape. Kaposi's sarcoma is a cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and ... Read More
-
Osteonecrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Osteonecrosis (Musculoskeletal Disorders) pipeline landscape. Osteonecrosis is bone death caused by poor blood supply to the area. It is most common in the hip and shoulder, but can affect other large joints ... Read More
-
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape. Chronic lymphocytic leukemia (CLL) is a type of cancer that starts from white blood cells (called lymphocytes) in the ... Read More
-
Asia-Pacific Cancer Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... routine care in many healthcare facilities and had an impact on healthcare systems all around the world, putting susceptible cancer patients in serious danger. The strict lockdowns and government regulations intended to slow down the ... Read More
-
Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development, 2022, provides an overview of the Gouty Arthritis (Gout) (Musculoskeletal Disorders) pipeline landscape. Gout is a type of arthritis where swelling and severe pain develops in joints, especially at the base of the big ... Read More
-
Small Molecule Drug Discovery Market - Growth, Trends, COVID-19 Impact, and Forecast (2022 - 2027)
... the COVID-19 pandemic, the health systems of countries have been heavily investing in research and development to combat the virus. Research groups across the world have started identifying small molecule drugs for the treatment of ... Read More
-
Hepatitis Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... health care services has had a substantial impact on the delivery of care and outcomes for patients with chronic diseases. Therefore, there has been a decline in the treatment, diagnosis, and follow-up of patients with ... Read More
-
Gliosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Gliosarcoma (Oncology) pipeline landscape. Gliosarcoma is a type of brain tumor that originates from glial cells. The tumor grows rapidly and symptom will vary depending on the exact location and size of ... Read More
-
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Leukemia (CML, Chronic Myeloid Leukemia) - Drugs In Development, 2022, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, ... Read More
-
Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Gallbladder Cancer (Oncology) pipeline landscape. Gallbladder cancer is a cancer that starts in the gallbladder. Symptoms include abdominal pain, nausea and/or vomiting, jaundice, loss of appetite, fever, itchy skin, dark ... Read More
-
Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... 'Insulin Like Growth Factor I - Drugs In Development, 2022'; Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) pipeline Target constitutes close to 10 molecules. Out of which approximately 7 ... Read More
Research Assistance
